112 related articles for article (PubMed ID: 23163592)
1. Meta-analysis: Barrett's oesophagus and the risk of colonic tumours.
Andrici J; Tio M; Cox MR; Eslick GD
Aliment Pharmacol Ther; 2013 Feb; 37(4):401-10. PubMed ID: 23163592
[TBL] [Abstract][Full Text] [Related]
2. Meta analysis: Cancer risk in Barrett's oesophagus.
Thomas T; Abrams KR; De Caestecker JS; Robinson RJ
Aliment Pharmacol Ther; 2007 Dec; 26(11-12):1465-77. PubMed ID: 17900269
[TBL] [Abstract][Full Text] [Related]
3. The prevalence of colonic neoplasia in patients with Barrett's esophagus: prospective assessment in patients 50-80 years old.
Poorman JC; Lieberman DA; Ippoliti AF; Weber LJ; Weinstein WM
Am J Gastroenterol; 1997 Apr; 92(4):592-6. PubMed ID: 9128305
[TBL] [Abstract][Full Text] [Related]
4. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis.
Desai TK; Krishnan K; Samala N; Singh J; Cluley J; Perla S; Howden CW
Gut; 2012 Jul; 61(7):970-6. PubMed ID: 21997553
[TBL] [Abstract][Full Text] [Related]
5. Barrett's oesophagus is not a risk factor for colonic neoplasia: a case-control study.
Laitakari R; Laippala P; Isolauri J
Ann Med; 1995 Aug; 27(4):499-502. PubMed ID: 8519512
[TBL] [Abstract][Full Text] [Related]
6. Incidence of colorectal cancer in a population-based cohort of patients with Barrett's oesophagus.
Murphy SJ; Anderson LA; Mainie I; Fitzpatrick DA; Johnston BT; Watson RG; Gavin AT; Murray LJ
Scand J Gastroenterol; 2005 Dec; 40(12):1449-53. PubMed ID: 16316894
[TBL] [Abstract][Full Text] [Related]
7. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
Gut; 2004 Aug; 53(8):1070-4. PubMed ID: 15247170
[TBL] [Abstract][Full Text] [Related]
8. Multicentre prospective controlled study of Barrett's oesophagus and colorectal adenomas. Groupe d'Etude de l'Oesophage de Barrett.
Cauvin JM; Goldfain D; Le Rhun M; Robaszkiewicz M; Cadiot G; Carpentier S; Rotenberg A; Mignon M; Boyer J; Galmiche JP
Lancet; 1995 Nov; 346(8987):1391-4. PubMed ID: 7475821
[TBL] [Abstract][Full Text] [Related]
9. Leptin and the risk of Barrett's oesophagus.
Kendall BJ; Macdonald GA; Hayward NK; Prins JB; Brown I; Walker N; Pandeya N; Green AC; Webb PM; Whiteman DC;
Gut; 2008 Apr; 57(4):448-54. PubMed ID: 18178609
[TBL] [Abstract][Full Text] [Related]
10. Surveillance in Barrett's oesophagus: will a strategy focused on a high-risk group reduce mortality from oesophageal adenocarcinoma?
Quera R; O'Sullivan K; Quigley EM
Endoscopy; 2006 Feb; 38(2):162-9. PubMed ID: 16479424
[TBL] [Abstract][Full Text] [Related]
11. Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications.
Ladanchuk TC; Johnston BT; Murray LJ; Anderson LA;
Scand J Gastroenterol; 2010 Dec; 45(12):1397-403. PubMed ID: 20626305
[TBL] [Abstract][Full Text] [Related]
12. Barrett's oesophagus and colonic tumours.
Sontag SJ; Schnell TG; Chejfec G; O'Connell S; Stanley MM; Best W; Chintam R; Nemchausky B; Wanner J; Moroni B
Lancet; 1985 Apr; 1(8435):946-9. PubMed ID: 2859411
[TBL] [Abstract][Full Text] [Related]
13. Cancer risk in Barrett's oesophagus.
Dias Pereira A; Suspiro A; Chaves P
Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
[TBL] [Abstract][Full Text] [Related]
14. Modelling a population with Barrett's oesophagus from oesophageal adenocarcinoma incidence data.
Van Blankenstein M; Looman CW; Kruijshaar ME; Siersema PD; Kuipers EJ; Bytzer P
Scand J Gastroenterol; 2007 Mar; 42(3):308-17. PubMed ID: 17354109
[TBL] [Abstract][Full Text] [Related]
15. Rising incidence of clinically evident Barrett's oesophagus in The Netherlands: a nation-wide registry of pathology reports.
Post PN; Siersema PD; Van Dekken H
Scand J Gastroenterol; 2007 Jan; 42(1):17-22. PubMed ID: 17190757
[TBL] [Abstract][Full Text] [Related]
16. Daily use of non-steroidal anti-inflammatory drugs is less frequent in patients with Barrett's oesophagus who develop an oesophageal adenocarcinoma.
Tsibouris P; Hendrickse MT; Isaacs PE
Aliment Pharmacol Ther; 2004 Sep; 20(6):645-55. PubMed ID: 15352913
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis: oral bisphosphonates and the risk of oesophageal cancer.
Andrici J; Tio M; Eslick GD
Aliment Pharmacol Ther; 2012 Oct; 36(8):708-16. PubMed ID: 22966908
[TBL] [Abstract][Full Text] [Related]
18. Should patients with Barrett's oesophagus be kept under surveillance? The case for.
Armstrong D
Best Pract Res Clin Gastroenterol; 2008; 22(4):721-39. PubMed ID: 18656826
[TBL] [Abstract][Full Text] [Related]
19. Effect of proton pump inhibitors on markers of risk for high-grade dysplasia and oesophageal cancer in Barrett's oesophagus.
Hillman LC; Chiragakis L; Shadbolt B; Kaye GL; Clarke AC
Aliment Pharmacol Ther; 2008 Feb; 27(4):321-6. PubMed ID: 18047565
[TBL] [Abstract][Full Text] [Related]
20. Hiatal hernia and the risk of Barrett's esophagus.
Andrici J; Tio M; Cox MR; Eslick GD
J Gastroenterol Hepatol; 2013 Mar; 28(3):415-31. PubMed ID: 22694245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
